Automate Your Wheel Strategy on NUTX
With Tiblio's Option Bot, you can configure your own wheel strategy including NUTX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NUTX
- Rev/Share 122.4079
- Book/Share 53.8977
- PB 2.2511
- Debt/Equity 1.7318
- CurrentRatio 2.274
- ROIC 0.265
- MktCap 483295440.0
- FreeCF/Share 13.6269
- PFCF 6.9542
- PE 4.5853
- Debt/Assets 0.448
- DivYield 0
- ROE 0.8295
- Rating A
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | NUTX | Maxim Group | -- | Buy | -- | $45 | Sept. 18, 2024 |
News
Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report -- Hagens Berman
Published: August 15, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company's disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
Published: August 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report – Hagens Berman
Published: August 12, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN FRANCISCO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution (“IDR”) vendor HaloMD.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
Published: August 11, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Aug. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX
Published: July 31, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , July 31, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Nutex Health (NUTX) Shares Fall Amid Critical Blue Orca Report -- Hagens Berman
Published: July 28, 2025 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO , July 28, 2025 /PRNewswire/ -- On July 22, 2025, investors in Nutex Health Inc. (NASDAQ: NUTX) saw the price of their shares significantly fall after activist investment firm Blue Orca Capital published a critical report about Nutex and its involvement with independent dispute resolution ("IDR") vendor HaloMD. Blue Orca's accusations have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Nutex may have misled investors about the propriety of steps taken in response to recent federal protections for consumers and urges Nutex investors who suffered substantial losses to submit your losses now.
Read More
Securities Fraud Investigation Into Nutex Health Inc. (NUTX) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Published: July 25, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On July 22, 2.
Read More
INVESTOR ALERT: Investigation of Nutex Health Inc. (NUTX) Announced by Holzer & Holzer, LLC
Published: July 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
ATLANTA, July 23, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX) complied with federal securities laws. On July 22, 2025, Blue Orca Capital released a report regarding, among other things, Nutex's reimbursement rates. Following this news, the price of the Company's stock dropped.
Read More
Nutex Health: At An Inflection Point
Published: July 16, 2025 by: Seeking Alpha
Sentiment: Positive
Nutex Health's financial turnaround is driven by IDR wins, robust revenue growth, and a superior urban microhospital model with industry-leading profitability. Shares are deeply undervalued at 2.1x EV/EBITDA and >30% FCF yield, with significant upside as the market underappreciates Nutex's earnings power and cash flow. Management's heavy insider ownership and consistent share purchases signal long-term commitment and confidence in the business model's sustainability.
Read More
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
Published: June 02, 2025 by: PRNewsWire
Sentiment: Neutral
HOUSTON , June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2025 annual meeting to be held on July 14, 2025 at 10:00 am Central Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2025 . We look forward to hosting you at our virtual shareholder meeting and encourage you to participate …
Read More
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong Momentum
Published: May 29, 2025 by: Seeking Alpha
Sentiment: Positive
NUTX is transforming from a turnaround story to a high-growth, high-risk play, driven by explosive revenue and profitability from its micro-hospital model. The company's financials show triple-digit revenue growth, margin expansion, and strong operating leverage, with positive analyst sentiment and technical momentum. Key risks include heavy reliance on arbitration revenue, significant lease liabilities, and regulatory uncertainty, making this a volatile but compelling opportunity.
Read More
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
Published: May 22, 2025 by: PRNewsWire
Sentiment: Neutral
HOUSTON , May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the …
Read More
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
Published: May 14, 2025 by: Seeking Alpha
Sentiment: Neutral
Nutex Health Inc. (NASDAQ:NUTX ) Q1 2025 Earnings Conference Call May 14, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - IR Manager Tom Vo - Chairman and CEO Jon Bates - CFO Warren Hosseinion - President Josh DeTillio - COO Conference Call Participants Bill Sutherland - The Benchmark Company Thomas McGovern - Maxim Group Gene Mannheimer - Freedom Capital Markets Joshua Cohen - Westbury Capital Operator Greetings. Welcome to Nutex Health's First Quarter 2025 Financial Results Conference Call.
Read More
Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral
HOUSTON , May 7, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2025 after the close of the stock market on Tuesday, May 13, 2025. The Company will discuss those results on a conference call on Wednesday, May 14, 2025, at 10:30 a.m.
Read More
6 Stocks Showing Momentum As The Market Rebounds
Published: April 29, 2025 by: Benzinga
Sentiment: Positive
Don't call it a comeback, but the market attempted to rally last week after a worrisome Monday decline. The S&P 500 closed above 5500 on Friday for the first time since President Donald Trump announced a 90-day pause on levying his reciprocal tariffs.
Read More
Nutex Health to Present at the EDPMA Solutions Summit 2025
Published: March 20, 2025 by: PRNewsWire
Sentiment: Neutral
HOUSTON , March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO.
Read More
About Nutex Health, Inc. (NUTX)
- IPO Date 2022-04-04
- Website https://www.nutexhealth.com
- Industry Medical - Healthcare Information Services
- CEO Thomas T. Vo
- Employees 800